Literature DB >> 11911295

Symptom assessment in advanced palliative home care for cancer patients using the ESAS: clinical aspects.

P A Heedman1, P Strang.   

Abstract

UNLABELLED: Four hundred and thirty-one cancer patients were assessed with the ESAS and a VAS-QoL at admission to Hospital-based home care (HBHC) and subsequently.
RESULTS: Pain and nausea were well-controlled (mean 2.5 and 1.8) whereas patients were less satisfied with appetite, activity and sense of well-being. Dyspnoea and anxiety (lung cancer, p<0.001 and p<0.01) and pain (prostate cancer, p<0.01), were related to diagnosis while activity, drowsiness, appetite and well-being to survival (p<0.05 to p<0.001). The correlations between individual symptoms and well-being were low (0.2-0.5), whereas the correlation between well-being and the Symptom Distress Score (SDS) was 0.76. "Well-being" was a better word to use than QoL. DISCUSSION: ESAS is useful in HBHC and data show that symptoms other than merely pain and nausea are of importance. As the global measurement (one VAS) of well-being has a high correlation with SDS, this single measurement may be clinically adequate for quality assurance of symptom control in dying cancer patients.

Entities:  

Mesh:

Year:  2001        PMID: 11911295

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Dyspnea in lung cancer patients: a systematic review.

Authors:  Ganesan Kathiresan; Reynold F Clement; Meera T Sankaranarayanan
Journal:  Lung Cancer (Auckl)       Date:  2010-11-22

2.  Edmonton symptom assessment scale: Italian validation in two palliative care settings.

Authors:  Cecilia Moro; Cinzia Brunelli; Guido Miccinesi; Mauro Fallai; Piero Morino; Massimo Piazza; Roberto Labianca; Carla Ripamonti
Journal:  Support Care Cancer       Date:  2005-06-04       Impact factor: 3.603

3.  Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study.

Authors:  Filomena Narducci; Roberta Grande; Lucia Mentuccia; Tiziana Trapasso; Isabella Sperduti; Emanuela Magnolfi; Anna Maria Fariello; Donatello Gemma; Teresa Gamucci
Journal:  Support Care Cancer       Date:  2011-06-19       Impact factor: 3.603

4.  Reduction in symptoms for homebound patients receiving home-based primary and palliative care.

Authors:  Katherine Ornstein; Ania Wajnberg; Halley Kaye-Kauderer; Gary Winkel; Linda DeCherrie; Meng Zhang; Theresa Soriano
Journal:  J Palliat Med       Date:  2013-06-08       Impact factor: 2.947

5.  Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study.

Authors:  Knut Jørgen Labori; Marianne Jensen Hjermstad; Torunn Wester; Trond Buanes; Jon Håvard Loge
Journal:  Support Care Cancer       Date:  2006-04-07       Impact factor: 3.603

6.  Symptom evaluation in palliative medicine: patient report vs systematic assessment.

Authors:  Jade Homsi; Declan Walsh; Nilo Rivera; Lisa A Rybicki; Kristine A Nelson; Susan B Legrand; Mellar Davis; Michael Naughton; Dragoslav Gvozdjan; Hahn Pham
Journal:  Support Care Cancer       Date:  2006-01-10       Impact factor: 3.603

7.  The Edmonton symptom assessment system--what do patients think?

Authors:  Sharon Watanabe; Cheryl Nekolaichuk; Crystal Beaumont; Asifa Mawani
Journal:  Support Care Cancer       Date:  2008-10-25       Impact factor: 3.603

8.  Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.

Authors:  M N Yogananda; Valliappan Muthu; Kuruswamy Thurai Prasad; Adarsh Kohli; Digambar Behera; Navneet Singh
Journal:  Support Care Cancer       Date:  2017-10-12       Impact factor: 3.603

9.  Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers.

Authors:  Anne E Utech; Eiriny M Tadros; Teresa G Hayes; Jose M Garcia
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-31       Impact factor: 12.910

10.  A review of the reliability and validity of the Edmonton Symptom Assessment System.

Authors:  L A Richardson; G W Jones
Journal:  Curr Oncol       Date:  2009-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.